Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,829 | -2,638 | -1,990 | -878 | -3,678 |
| Depreciation Amortization | 842 | 718 | 472 | 149 | 419 |
| Accounts receivable | 30 | 30 | 25 | -41 | -31 |
| Other Working Capital | 1,656 | 650 | 307 | 196 | 1,448 |
| Other Operating Activity | 65 | -3 | 1 | 50 | 311 |
| Operating Cash Flow | $-1,237 | $-1,243 | $-1,185 | $-524 | $-1,531 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -5 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $-5 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,200 | 1,200 | 1,200 | 600 | 1,257 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 365 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -43 |
| Financing Cash Flow | $1,200 | $1,200 | $1,200 | $600 | $1,580 |
| Beginning Cash Position | 50 | 50 | 50 | 50 | 6 |
| End Cash Position | 13 | 7 | 65 | 126 | 50 |
| Net Cash Flow | $-37 | $-43 | $15 | $76 | $44 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,237 | -1,243 | -1,185 | -524 | -1,531 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -5 |
| Free Cash Flow | -1,237 | -1,243 | -1,185 | -524 | -1,536 |